Celularity Inc. (CELUW)
NASDAQ: CELUW
· Real-Time Price · USD
0.06
0.03 (93.55%)
At close: May 02, 2025, 3:45 PM
93.55% (1D)
| Bid | 0.06 |
| Market Cap | 56.24M |
| Revenue (ttm) | 48.2M |
| Net Income (ttm) | -35.05M |
| EPS (ttm) | -0.87 |
| PE Ratio (ttm) | -0.07 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.06 |
| Volume | 48,154 |
| Avg. Volume (20D) | 21,002.989 |
| Open | 0.04 |
| Previous Close | 0.03 |
| Day's Range | 0.04 - 0.09 |
| 52-Week Range | 0.04 - 0.09 |
| Beta | 0.58 |
About CELUW
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 19, 2021
Employees 120
Stock Exchange NASDAQ
Ticker Symbol CELUW
Website https://www.celularity.com